Literature DB >> 299861

Alpha-1 antitrypsin in childhood asthma.

R H Schwartz, J D Van Ess, D E Johnstone, E M Dreyfuss, M A Abrishami, H Chai.   

Abstract

Alpha-1 antitrypsin (AAT) phenotypes and serum levels were studied in two childhood perennial asthmatic populations. The first was an ambulatory, mostly mild nonsteroid-dependent group living in Rochester, N.Y. The second was a more severe mostly steroid-dependent group residing at an asthma residential treatment center in Denver, Colo. The prevalences of alpha-1 antitrypsin protease inhibitor (Pi) tyes were the same for bothe groups and similar to prevalences in a random population. Alpha-1 antitrypsin serum levels were significantly elevated for the mild nonsteroid-dependent group when compared to the more severe steroid-dependent group. The steroid-dependent group had serum levels similar to a group of nonasthmatic control children. These findings indicate that there is not a strong association of alpha-1 antitrypsin Pi variants such as Pi MZ or Pi MS with more severe asthma. Elevated serum levels in the milk perennial asthmatic group may be the result of chronic inflammatory processes. Normal levels in the sterioid-dependent group may be the result of corticosteroid control of inflammation associated with asthma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299861     DOI: 10.1016/0091-6749(77)90173-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Pi Ecincinnati: a new alpha 1-antitrypsin allele in three Negro families.

Authors:  G Hug; G Chuck; T M Slemmer; M K Fagerhol
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

2.  IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells.

Authors:  Siyoung Lee; Dong-Ki Choi; Areum Kwak; Sinae Kim; Tam Thanh Nguyen; Gaae Gil; Eunhye Kim; Kwang Ha Yoo; In Ae Kim; Youngmin Lee; Hyunjhung Jhun; Edward D Chan; Xiyuan Bai; Hyunwoo Kim; Yong-Sung Kim; Soohyun Kim
Journal:  Immune Netw       Date:  2017-04-20       Impact factor: 6.303

3.  Signalling architectures can prevent cancer evolution.

Authors:  Leonardo Oña; Michael Lachmann
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.